参考文献/References:
1 Bjorklund A,Lindvall O.Cell replacement therapies for central nervous system disorders[J].Nature Neurosci,2000,3(6):537-544.
2 Lindvall O,Rehncrona S,Gustuvii B,et al.Fetal dopamine-richmesencephalic grafts in parkinson’ disease[J].Lancet,1988,2(8626-8627):1483-1484.
3 Mckay R.Enhance proliferation,survival,and dopaminergic differentiation of CNS precursors in lowered oxygen[J].J Neurosci,2000,20(19):7377-7384.
4 Mckay R.Stem cell-hype and hope[J].Nature,2000,406(6794):361-364.
5 Studer L,Ta:ar V,Mckay RDG.Transplantation of expended mesencephalic precursors leads to recovery in parkinsonina rats[J].Nature Neurosci,1998,1(4):290-295.
6 Haque NS,LeBlanc CJ,Jsacson 0.Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum:y a su:set of aldehyde dehydrogenase-postive TH neurons[J].Cell Transplant,1997,6(3):239-248.
7 Poewe W,Scherfler C.Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice[J].Mov Disorde,2003,18(7):16-21.
8 Remy P,Samson Y,Hantraye P,et al.Clinical 18F-fluorodopa uptake in five grafted parkinsonian patients[J].Ann Neurol,1995,38(4):580-588.
9 Kuwabara H,Reith J.Human striatal L-dopa decar:oxylase activity estimate in vivo using 6-[18F] fluorodopa and positron emis-sion to-mography:error analysis and application to normal subjects[J]. J Cereb Blood Flow Metab,1993,13(1):43-56.
10 Snow BJ,Tooyama I,McGeer EG,et al.Human positron emission tomographic[18F] fluorodopa studies correlate with dopamine cell counts and levels[J].Ann neurol,1993,34(3):324-330.
11 Kordower JH,Rosenstein JM,Collier TJ,et al.Functional fetal nigral in a patient with Parkinson’s disease:chemoanatomic,ultra-structural,and metabolic studies[J].J Comp Neural,1996,370(2):203-230.
12 Pate BD,Kawamata T,Yamada T,et al.Correlate of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices[J].Ann Neurol,1993,34(3):331-338.
13 Yee RE,Huang SC,Stour DB,et al.Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys:in vivo and in vitro investigation[J].J Neurochem,2000,74(3):1147-1157.
14 Freed CR.Transplantation of embryonic dopamine neurons for severe Parkinson’s disease[J].New Engl J Med,2001,344(10):710-719.
15 Cochen V,Ribeiro MJ,Nguyen JP.Transplantation in parkinson’s disease:PET changes correlate with the amount of grafted tissue[J].Mov Disorde,2003,18(8):928-932.
16 Ribeiro MJ,Vaughan RA,Lo?h C,et al.Dopaminergic function and dopamine transporter density assessed with PET in parkinson’s disease[J].Arch Neural,2002,59(4):580-586.
17 Wenning GK,Odin P,Morrish P,et al.Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease[J].Ann Neurol,1997,42(1):95-107.
18 Bjorklund A.Dopaminergic transplants in experimental parkinsonism:Cellular mechamisms of graft-induced functional recovery[J].Curr Opin Neurobiol,1992,2(5):683-689.
19 Schumacher JM,Ellias SA,Palmer EP,et al.transplantation of embryonic porcinemesencephalic tissue in patients with PD[J].Neurol,2000,54(5):1042-1050.
相似文献/References:
[1]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[2]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[3]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):1.
[4]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):10.
[5]闫卫红.Raclopride在帕金森病PET中的应用[J].国际放射医学核医学杂志,2005,29(1):27.
YAN Wei-hong.Application of raclopride PET in Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):27.
[6]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):148.
[7]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):197.
[8]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):201.
[9]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):205.
[10]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):209.
[11]董爱生,田建明.PET、SPECT及MRS在帕金森病诊断中的应用[J].国际放射医学核医学杂志,2005,29(6):244.
DONG Ai-sheng,TIAN Jian-ming.The application of PET、SPECT and MRS in Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):244.
[12]田季雨.PET在帕金森病病理机制研究中的应用近况[J].国际放射医学核医学杂志,2003,27(2):53.
TIAN Ji-yu.Recent application of PET in the pathological mechanisms of PD[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):53.